Tooth discoloration after treatment with linezolid

Pharmacotherapy

Volumn 23, Issue 5, 2003, Pages 682-685

  Matson, Kelly L ^a   Miller, Susan E ^b  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFALEXIN; COTRIMOXAZOLE; DICLOXACILLIN; FLUCONAZOLE; LAMIVUDINE; LINEZOLID; LOPINAVIR; OXACILLIN; OXAZOLIDINONE DERIVATIVE; RITONAVIR; STAVUDINE; TETRACYCLINE;

ARTICLE; BONE MARROW SUPPRESSION; BRONCHITIS; BURN; BURNING SENSATION; CASE REPORT; CELLULITIS; CLINICAL TRIAL; CONVULSION; DENTIST; DIARRHEA; DRUG TOLERABILITY; ENAMEL; EOSINOPHILIA; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUTH EXAMINATION; MOUTH HYGIENE; NAUSEA; NEUTROPENIA; PHYSICIAN; PNEUMONIA; PNEUMOTHORAX; PRESCRIPTION; PREVENTIVE DENTISTRY; RASH; SCHOOL CHILD; SEPTICEMIA; SOFT TISSUE INFECTION; TONGUE DISCOLORATION; TONGUE DISEASE; TOOTH COLOR; TOOTH DISEASE; VOMITING;

ACETAMIDES; ANTI-BACTERIAL AGENTS; CELLULITIS; CHILD; FEMALE; HIV INFECTIONS; HUMANS; METHICILLIN RESISTANCE; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TOOTH DISCOLORATION;

EID: 0038185306     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.5.682.32207     Document Type: Article

References (31)

1. Noskin GA. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: emerging problems and new prospects for management. Ann Acad Med Singapore 2001;30:320-31.
2. Jones RN. Resistance patterns among nosocomial pathogens: trends over the past few years. Chest 2001;119:397S-404.
3. Moreno F, Crisp C, Jorgensen JH, Patterson JE. Methicillinresistant Staphylococcus aureus as a community organism. Clin Infect Dis 1995;21:1308-12.
4. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593-8.
5. Frank AL, Marcinak JF, Mangat PD, Schreckenberger PC. Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr Infect Dis J 1999;18:993-1000.
6. Hussain FM, Boyle-Vavra S, Bethel CD, Daum RS. Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. Pediatr Infect Dis J 2000;19:1163-6.
7. Naimi TS, LeDell KH, Boxrud DJ, et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis 2001;33:990-6.
8. Sattler CA, Mason EO Jr, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J 2002;21:910-17.
9. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. JAMA 1999;282:1123-5.
10. Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997. MMWR Morb Mortal Wkly Rep 1997;46:765-6.
11. Plouffe JF. Emerging therapies for serious gram-positive bacterial infections: a focus on linezolid. Clin Infect Dis 2000;31:S144-9.
12. Paradisi F, Giampaolo C, Messeri D. Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics. Med Clin North Am 2001;85:1-17.
13. Daum RS, Seal JB. Evolving antimicrobial chemotherapy for Staphylococcus aureus infections: our backs to the wall. Crit Care Med 2001;29:N92-6.
14. Maskalyk J. Antimicrobial resistance takes another step forward [editorial]. Can Med Assoc J 2002;167:375.
15. Centers for Disease Control and Prevention. Vancomycin-resistant Staphylococcus aureus: Pennsylvania, 2002. JAMA 2002;288:2116.
16. Diekema DJ, Jones RN. Oxazolidinone antibiotics. Lancet 2001;358:1975-82.
17. Bradley JS. Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines. Pediatr Infect Dis J 2002;21:592-8.
18. Pharmacia & Upjohn. Zyvox (linezolid) package insert. Kalamazoo, MI; December 2002.
19. Kearns GL, Abdel-Rahman SM, Blumer JL, et al. Single-dose pharmacokinetics of linezolid in infants and children. Pediatr Infect Dis J 2000;19:1178-84.
20. Bruss JB, Smith LG, Duvall SE, et al. Safety and tolerance of linezolid: adverse events reported in phase III trials. Presented at the 40th interscience conference on antimicrobial agents and chemotherapy, Toronto, Ontario, Canada, September 17-20, 2000.
21. Food and Drug Administration Advisory Committee. Presentation: Zyvox (linezolid). Available from http://www.fda.gov/ohrms/dockets/ac/00/slides/3597s1c/ s1d001.htm. Accessed March 1, 2003.
22. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
23. Dresser LD, Rybak MJ. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials. Pharmacotherapy 1998;18:456-62.
24. Noskin GA. Linezolid [editorial]. Drugs 2000;59:828.
25. Livingston HM, Dellinger TM. Intrinsic staining of teeth secondary to tetracycline. Ann Pharmacother 1998;32:607.
26. Dodd MA, Dole EJ, Troutman WG, Bennahum DA. Minocycline-associated tooth staining. Ann Pharmacother 1998;32:887-9.
27. Stevens DL, Smith LG, Bruss JB, et al. Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother 2000;44:3408-13.
28. Moellering RC Jr. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 2003;138:135-42.
29. Kaplan SL, Patterson L, Edwards KM, et al. Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Pediatr Infect Dis J 2001;20:488-94.
30. Pharmacia & Upjohn. Zyvox (linezolid) package insert. Kalamazoo, MI;January 2002.
31. Atkins JL, Hidvegi N, Teare L, Dziewulski P. The use of linezolid in the treatment of vancomycin-resistant enterococcal septicaemia in two patients with burn injuries. Burns 2002;28:185-8.